Table 2.
Multivariate analysis for OS of R/M HNSCC patients.
| Factors | Sig. | Exp(B) | 95.0%Cl for Exp(B) | |
|---|---|---|---|---|
| Lower | Upper | |||
| Sex (Male vs Female) |
.977 | .989 | .466 | 2.102 |
| Age (≥60vs<60) |
.796 | 1.097 | .543 | 2.215 |
| Primary tumor site (Oral vs Oropharyngeal) | .766 | .816 | .215 | 3.101 |
| Recurrence pattern | .673 | 1.161 | .581 | 2.319 |
| HPV infection (Positive vs Negative) |
.694 | 1.593 | .157 | 16.160 |
| ECOG PS(1 vs 2) | .307 | 1.596 | .650 | 3.919 |
| First-line therapy vs ≥2nd line therapy | .018 | .380 | .171 | .845 |
| irAEs vs No irAEs | .018 | .297 | .108 | .813 |